<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font3" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font4" size="10" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="10" family="SymbolMT" color="#000000"/>
	<fontspec id="font6" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font7" size="9" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font8" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
<text top="42" left="57" width="199" height="7" font="font0" id="p1_t1" reading_order_no="1" segment_no="0" tag_type="title">Arthritis Research &amp; Therapy Vol 6 No 6    Jönsen et al.<b>Arthritis Research &amp; Therapy</b></text>
<text top="735" left="18" width="19" height="8" font="font3" id="p1_t2" reading_order_no="0" segment_no="20" tag_type="text">R558</text>
<text top="85" left="57" width="240" height="9" font="font4" id="p1_t3" reading_order_no="2" segment_no="1" tag_type="text">les have been suggested as a minor risk factor in suscepti-<i>et al.</i></text>
<text top="97" left="57" width="240" height="9" font="font4" id="p1_t4" reading_order_no="3" segment_no="1" tag_type="text">bility to SLE in several populations [8,10,12]. Interleukin-1</text>
<text top="109" left="57" width="240" height="9" font="font4" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">receptor antagonist (IL-1Ra) is a naturally occurring com-</text>
<text top="120" left="57" width="240" height="9" font="font4" id="p1_t6" reading_order_no="5" segment_no="1" tag_type="text">petitive inhibitor of IL-1. The IL-1Ra gene contains a poly-<a href=""> [8,10,12]. Interleukin-1</a></text>
<text top="132" left="57" width="240" height="9" font="font4" id="p1_t7" reading_order_no="6" segment_no="1" tag_type="text">morphism in intron 2 consisting of a variable number of</text>
<text top="144" left="57" width="240" height="9" font="font4" id="p1_t8" reading_order_no="7" segment_no="1" tag_type="text">copies of an 86-base-pair repeat sequence (two, three,</text>
<text top="156" left="57" width="240" height="9" font="font4" id="p1_t9" reading_order_no="8" segment_no="1" tag_type="text">four, five, or six copies) [13]. An association has been found</text>
<text top="167" left="57" width="240" height="9" font="font4" id="p1_t10" reading_order_no="9" segment_no="1" tag_type="text">between the IL-1Ra 2 allele and SLE [13,14]. Multiple</text>
<text top="179" left="57" width="240" height="9" font="font4" id="p1_t11" reading_order_no="10" segment_no="1" tag_type="text">genes are involved in the development of SLE, and the rel-<a href="">es) [13]. An</a> association has been found</text>
<text top="191" left="57" width="241" height="9" font="font4" id="p1_t12" reading_order_no="11" segment_no="1" tag_type="text">ative importance of these genes may vary between popula-<a href="">13,14]. Multiple</a></text>
<text top="203" left="57" width="240" height="9" font="font4" id="p1_t13" reading_order_no="12" segment_no="1" tag_type="text">tions and with environmental exposure. We investigated</text>
<text top="214" left="57" width="240" height="9" font="font4" id="p1_t14" reading_order_no="13" segment_no="1" tag_type="text">common variant alleles involved in the immune response,</text>
<text top="226" left="57" width="240" height="9" font="font4" id="p1_t15" reading_order_no="14" segment_no="1" tag_type="text">immune complex clearance, and regulation of inflammation,</text>
<text top="238" left="57" width="241" height="9" font="font4" id="p1_t16" reading_order_no="15" segment_no="1" tag_type="text">with the hypothesis that combinations of polymorphic can-</text>
<text top="250" left="57" width="240" height="9" font="font4" id="p1_t17" reading_order_no="16" segment_no="1" tag_type="text">didate genes could have synergistic effects on disease</text>
<text top="261" left="57" width="241" height="9" font="font4" id="p1_t18" reading_order_no="17" segment_no="1" tag_type="text">susceptibility. Therefore, we have analysed polymorphisms</text>
<text top="270" left="57" width="240" height="12" font="font4" id="p1_t19" reading_order_no="18" segment_no="1" tag_type="text">in the genes HLA DR, HLA DQ, C4A, Fc γ RIIa, Fc γ RIIIa,</text>
<text top="285" left="57" width="241" height="9" font="font4" id="p1_t20" reading_order_no="19" segment_no="1" tag_type="text">MBL, and IL-1Ra and their association with the develop-</text>
<text top="297" left="57" width="53" height="9" font="font4" id="p1_t21" reading_order_no="20" segment_no="1" tag_type="text">ment of SLE.</text>
<text top="320" left="57" width="121" height="10" font="font6" id="p1_t22" reading_order_no="21" segment_no="7" tag_type="title">Materials and methods</text>
<text top="332" left="57" width="36" height="8" font="font7" id="p1_t23" reading_order_no="22" segment_no="8" tag_type="title">Patients</text>
<text top="344" left="57" width="240" height="9" font="font4" id="p1_t24" reading_order_no="23" segment_no="9" tag_type="text">The study population comprised 124 female and 14 male</text>
<text top="355" left="57" width="240" height="9" font="font4" id="p1_t25" reading_order_no="24" segment_no="9" tag_type="text">Caucasian SLE patients, and 200 blood donors (100 men,</text>
<text top="367" left="57" width="240" height="9" font="font4" id="p1_t26" reading_order_no="25" segment_no="9" tag_type="text">100 women) were used as controls. One hundred thirty-</text>
<text top="379" left="57" width="240" height="9" font="font4" id="p1_t27" reading_order_no="26" segment_no="9" tag_type="text">eight patients fulfilled four or more criteria of the American</text>
<text top="391" left="57" width="240" height="9" font="font4" id="p1_t28" reading_order_no="27" segment_no="9" tag_type="text">College of Rheumatology (ACR) classification for SLE<b>Materials and methods</b></text>
<text top="402" left="57" width="240" height="9" font="font4" id="p1_t29" reading_order_no="28" segment_no="9" tag_type="text">[15]. Five patients with a clinical SLE diagnosis were<b>Patients</b></text>
<text top="414" left="57" width="240" height="9" font="font4" id="p1_t30" reading_order_no="29" segment_no="9" tag_type="text">included in the study even though they fulfilled only three</text>
<text top="426" left="57" width="240" height="9" font="font4" id="p1_t31" reading_order_no="30" segment_no="9" tag_type="text">ACR classification criteria; these five patients had multisys-</text>
<text top="438" left="57" width="241" height="9" font="font4" id="p1_t32" reading_order_no="31" segment_no="9" tag_type="text">temic disease with an immunologic disorder, i.e. presence</text>
<text top="449" left="57" width="240" height="9" font="font4" id="p1_t33" reading_order_no="32" segment_no="9" tag_type="text">of anitnuclear antibodies and symptoms characteristic of</text>
<text top="461" left="57" width="240" height="9" font="font4" id="p1_t34" reading_order_no="33" segment_no="9" tag_type="text">SLE such as arthritis, photosensitivity, serositis, nephritis,</text>
<text top="473" left="57" width="240" height="9" font="font4" id="p1_t35" reading_order_no="34" segment_no="9" tag_type="text">thrombocytopenia, and leucopenia [16]. A breakdown of<a href="">[15]. Five</a> patients with a clinical SLE diagnosis were</text>
<text top="485" left="57" width="240" height="9" font="font4" id="p1_t36" reading_order_no="35" segment_no="9" tag_type="text">the ACR criteria is shown in Table 1. There were 129 fam-</text>
<text top="496" left="57" width="240" height="9" font="font4" id="p1_t37" reading_order_no="36" segment_no="9" tag_type="text">ilies with a single case of SLE and 14 families in which mul-</text>
<text top="508" left="57" width="240" height="9" font="font4" id="p1_t38" reading_order_no="37" segment_no="9" tag_type="text">tiple cases were recorded. However, from each multicase</text>
<text top="520" left="57" width="240" height="9" font="font4" id="p1_t39" reading_order_no="38" segment_no="9" tag_type="text">family, only the first family member with SLE diagnosis, the</text>
<text top="532" left="57" width="240" height="9" font="font4" id="p1_t40" reading_order_no="39" segment_no="9" tag_type="text">index case, was included in the statistical analysis. The</text>
<text top="543" left="57" width="241" height="9" font="font4" id="p1_t41" reading_order_no="40" segment_no="9" tag_type="text">mean age at diagnosis of the patients was 40 years (range<a href="">ia [16]. </a>A breakdown of</text>
<text top="555" left="57" width="241" height="9" font="font4" id="p1_t42" reading_order_no="41" segment_no="9" tag_type="text">10–83) and the mean disease duration was 16 years<a href=""> Table 1.</a> There were 129 fam-</text>
<text top="567" left="57" width="240" height="9" font="font4" id="p1_t43" reading_order_no="42" segment_no="9" tag_type="text">(range 1–42). The mean Systemic Lupus International Col-</text>
<text top="579" left="57" width="240" height="9" font="font4" id="p1_t44" reading_order_no="43" segment_no="9" tag_type="text">laborating Clinics/ACR-Damage Index score was 1.9</text>
<text top="590" left="57" width="240" height="9" font="font4" id="p1_t45" reading_order_no="44" segment_no="9" tag_type="text">(range 0–9) [17]. The study was approved by the local eth-</text>
<text top="602" left="57" width="136" height="9" font="font4" id="p1_t46" reading_order_no="45" segment_no="9" tag_type="text">ics committee at Lund University.</text>
<text top="626" left="57" width="73" height="8" font="font7" id="p1_t47" reading_order_no="46" segment_no="13" tag_type="title">Genetic analyses</text>
<text top="637" left="57" width="240" height="9" font="font4" id="p1_t48" reading_order_no="47" segment_no="15" tag_type="text">DNA was extracted by the salting-out method described by</text>
<text top="649" left="57" width="240" height="9" font="font4" id="p1_t49" reading_order_no="48" segment_no="15" tag_type="text">Miller and colleagues [18]. Analysis of genetic polymor-</text>
<text top="661" left="57" width="240" height="9" font="font4" id="p1_t50" reading_order_no="49" segment_no="15" tag_type="text">phism was predominantly performed by polymerase chain</text>
<text top="673" left="57" width="64" height="9" font="font4" id="p1_t51" reading_order_no="50" segment_no="15" tag_type="text">reaction (PCR).<a href=""> [17</a>]. The study was approved by the local eth-</text>
<text top="696" left="57" width="19" height="9" font="font8" id="p1_t52" reading_order_no="51" segment_no="17" tag_type="title">HLA</text>
<text top="708" left="57" width="240" height="9" font="font4" id="p1_t53" reading_order_no="52" segment_no="19" tag_type="text">HLA DR and DQ alleles were determined with PCR<b>Genetic analyses</b></text>
<text top="720" left="57" width="240" height="9" font="font4" id="p1_t54" reading_order_no="53" segment_no="19" tag_type="text">(Olerup SSP™ DQ-DR SSP Combi Tray, Olerup SSP AB,</text>
<text top="85" left="315" width="240" height="9" font="font4" id="p1_t55" reading_order_no="54" segment_no="2" tag_type="text">Stockholm, Sweden). However, a minority of the patients<a href="">eagues [18]. </a>Analysis of genetic polymor-</text>
<text top="97" left="315" width="241" height="9" font="font4" id="p1_t56" reading_order_no="55" segment_no="2" tag_type="text">had previously been typed with a lymphocytotoxicity test or</text>
<text top="109" left="315" width="240" height="9" font="font4" id="p1_t57" reading_order_no="56" segment_no="2" tag_type="text">by restriction fragment length polymorphism as described</text>
<text top="120" left="315" width="241" height="9" font="font4" id="p1_t58" reading_order_no="57" segment_no="2" tag_type="text">before [2]. C4A gene deletion was determined by PCR as<i>HLA</i></text>
<text top="132" left="315" width="240" height="9" font="font4" id="p1_t59" reading_order_no="58" segment_no="2" tag_type="text">described by Grant and colleagues [19], or in a few cases</text>
<text top="144" left="315" width="241" height="9" font="font4" id="p1_t60" reading_order_no="59" segment_no="2" tag_type="text">by analysis of restriction fragment length polymorphism and</text>
<text top="156" left="315" width="241" height="9" font="font4" id="p1_t61" reading_order_no="60" segment_no="2" tag_type="text">determination of MHC haplotypes [2]. With the presence</text>
<text top="167" left="315" width="241" height="9" font="font4" id="p1_t62" reading_order_no="61" segment_no="2" tag_type="text">of a DR3 allele together with a DQ2 and a C4AQ0 allele,</text>
<text top="179" left="315" width="240" height="9" font="font4" id="p1_t63" reading_order_no="62" segment_no="2" tag_type="text">due to C4A gene deletion, the subject was considered to</text>
<text top="191" left="315" width="241" height="9" font="font4" id="p1_t64" reading_order_no="63" segment_no="2" tag_type="text">have the haplotype HLA DR3-DQ2-C4AQ0, although fam-<a href="">before [2]. C4A ge</a>ne deletion was determined by PCR as</text>
<text top="203" left="315" width="240" height="9" font="font4" id="p1_t65" reading_order_no="64" segment_no="2" tag_type="text">ily studies were not uniformly performed to confirm this<a href="">ues [19], or in a few cases</a></text>
<text top="214" left="315" width="50" height="9" font="font4" id="p1_t66" reading_order_no="65" segment_no="2" tag_type="text">assumption.</text>
<text top="234" left="315" width="113" height="13" font="font5" id="p1_t67" reading_order_no="66" segment_no="3" tag_type="title">Fc γ RIIa gene polymorphism<a href="">ypes [2</a>]. With the presence</text>
<text top="250" left="315" width="241" height="9" font="font4" id="p1_t68" reading_order_no="67" segment_no="4" tag_type="text">The genetic polymorphism resulting in amino acid R or H in</text>
<text top="261" left="315" width="241" height="9" font="font4" id="p1_t69" reading_order_no="68" segment_no="4" tag_type="text">amino acid position 131 was determined as previously</text>
<text top="273" left="315" width="64" height="9" font="font4" id="p1_t70" reading_order_no="69" segment_no="4" tag_type="text">described [20].</text>
<text top="293" left="315" width="163" height="13" font="font5" id="p1_t71" reading_order_no="70" segment_no="5" tag_type="title">Analysis of Fc γ RIIIa gene polymorphism</text>
<text top="308" left="315" width="241" height="9" font="font4" id="p1_t72" reading_order_no="71" segment_no="6" tag_type="text">The analysis of the F/V polymorphism was performed</text>
<text top="320" left="315" width="165" height="9" font="font4" id="p1_t73" reading_order_no="72" segment_no="6" tag_type="text">essentially as previously described [21].<i>Fc</i></text>
<text top="344" left="315" width="103" height="9" font="font8" id="p1_t74" reading_order_no="73" segment_no="10" tag_type="title">MBL gene polymorphism</text>
<text top="355" left="315" width="240" height="9" font="font4" id="p1_t75" reading_order_no="74" segment_no="11" tag_type="text">Variants of MBL due to mutations at codon 52 (D), 54 (B),<i>RIIa gene polymorphism</i></text>
<text top="367" left="315" width="241" height="9" font="font4" id="p1_t76" reading_order_no="75" segment_no="11" tag_type="text">and 57 (C) in exon 1 of the MBL gene and promotor vari-</text>
<text top="379" left="315" width="241" height="9" font="font4" id="p1_t77" reading_order_no="76" segment_no="11" tag_type="text">ants at position -550 (H/L) and -221 (X/Y) were deter-</text>
<text top="391" left="315" width="240" height="9" font="font4" id="p1_t78" reading_order_no="77" segment_no="11" tag_type="text">mined by allele-specific PCR amplification, essentially as<a href="">scribed [20].</a></text>
<text top="402" left="315" width="241" height="9" font="font4" id="p1_t79" reading_order_no="78" segment_no="11" tag_type="text">described before [9]. The wild-type structural allele is des-<i>Analysis of Fc</i></text>
<text top="414" left="315" width="240" height="9" font="font4" id="p1_t80" reading_order_no="79" segment_no="11" tag_type="text">ignated A, while 0 is a description of the mutant alleles B,</text>
<text top="426" left="315" width="240" height="9" font="font4" id="p1_t81" reading_order_no="80" segment_no="11" tag_type="text">C, and D. Based on previously described associations<i>RIIIa gene polymorphism</i></text>
<text top="438" left="315" width="240" height="9" font="font4" id="p1_t82" reading_order_no="81" segment_no="11" tag_type="text">between MBL genotype and serum concentrations, which</text>
<text top="449" left="315" width="241" height="9" font="font4" id="p1_t83" reading_order_no="82" segment_no="11" tag_type="text">were confirmed in our 200 healthy controls, the MBL gen-<a href="">bed [21].</a></text>
<text top="461" left="315" width="240" height="9" font="font4" id="p1_t84" reading_order_no="83" segment_no="11" tag_type="text">otypes were divided into three groups. Group 1 (MBL-low)<i>MBL gene polymorphism</i></text>
<text top="473" left="315" width="240" height="9" font="font4" id="p1_t85" reading_order_no="84" segment_no="11" tag_type="text">consisted of patients with two structural mutant alleles (0/</text>
<text top="485" left="315" width="241" height="9" font="font4" id="p1_t86" reading_order_no="85" segment_no="11" tag_type="text">0) or on one haplotype a structural mutant allele together</text>
<text top="496" left="315" width="241" height="9" font="font4" id="p1_t87" reading_order_no="86" segment_no="11" tag_type="text">with another haplotype containing an LX promoter and the</text>
<text top="508" left="315" width="240" height="9" font="font4" id="p1_t88" reading_order_no="87" segment_no="11" tag_type="text">wild-type structural allele (ALX/0). Group 2 (MBL-interme-</text>
<text top="520" left="315" width="240" height="9" font="font4" id="p1_t89" reading_order_no="88" segment_no="11" tag_type="text">diate) consisted of patients with the promoters LX confer-<a href="">scribed before [9]. The w</a>ild-type structural allele is des-</text>
<text top="532" left="315" width="240" height="9" font="font4" id="p1_t90" reading_order_no="89" segment_no="11" tag_type="text">ring low serum MBL on both haplotypes but with normal</text>
<text top="543" left="315" width="240" height="9" font="font4" id="p1_t91" reading_order_no="90" segment_no="11" tag_type="text">structural alleles (ALX/ALX), or, alternatively, haplotypes</text>
<text top="555" left="315" width="241" height="9" font="font4" id="p1_t92" reading_order_no="91" segment_no="11" tag_type="text">with one mutant and one wild-type structural allele with a</text>
<text top="567" left="315" width="241" height="9" font="font4" id="p1_t93" reading_order_no="92" segment_no="11" tag_type="text">non-LX promoter together with the wild-type allele. Group</text>
<text top="579" left="315" width="241" height="9" font="font4" id="p1_t94" reading_order_no="93" segment_no="11" tag_type="text">3 (MBL-high) included patients with the A/A genotype and</text>
<text top="590" left="315" width="122" height="9" font="font4" id="p1_t95" reading_order_no="94" segment_no="11" tag_type="text">at least one non-LX promoter.</text>
<text top="614" left="315" width="110" height="9" font="font8" id="p1_t96" reading_order_no="95" segment_no="12" tag_type="title">IL-1Ra gene polymorphism</text>
<text top="626" left="315" width="240" height="9" font="font4" id="p1_t97" reading_order_no="96" segment_no="14" tag_type="text">Genetic polymorphism in the IL-1Ra gene was determined</text>
<text top="637" left="315" width="241" height="9" font="font4" id="p1_t98" reading_order_no="97" segment_no="14" tag_type="text">with a PCR essentially as previously described [13,22],</text>
<text top="649" left="315" width="142" height="9" font="font4" id="p1_t99" reading_order_no="98" segment_no="14" tag_type="text">although one primer was modified.</text>
<text top="673" left="315" width="183" height="9" font="font4" id="p1_t100" reading_order_no="99" segment_no="16" tag_type="text">Primers: 5'-CTC AGC AAC ACT CCT AT-3'</text>
<text top="696" left="315" width="141" height="9" font="font4" id="p1_t101" reading_order_no="100" segment_no="18" tag_type="text">5'-TTC CAC CAC ATG GAA C-3'</text>
</page>
</pdf2xml>
